Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blinded, Phase II, Randomized Control Trial to Study the Effects of Simvastatin in Patients With Uterine Leiomyoma

NCT03400826 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03400826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03400826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blinded, Phase II, Randomized Control Trial to Study the Effects of Simvastatin in Patients With Uterine Leiomyoma
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 20, 2018
Completion date
July 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibroid tumor, fibroid uterus, fibromyoma, leiomyoma, leiomyoma, uterine